Oragenics (NYSE:OGEN) Trading Down 4.6% - Time to Sell?

Oragenics, Inc. (NYSE:OGEN - Get Free Report)'s share price traded down 4.6% during mid-day trading on Thursday . The company traded as low as $3.34 and last traded at $3.53. 209,517 shares changed hands during mid-day trading, an increase of 105% from the average session volume of 102,268 shares. The stock had previously closed at $3.70.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen started coverage on shares of Oragenics in a research report on Thursday, May 15th. They set a "sell" rating on the stock.

Oragenics Stock Down 4.6%

The stock has a market cap of $75.81 million, a PE ratio of -0.50 and a beta of 0.94. The stock's fifty day moving average price is $5.43 and its 200 day moving average price is $7.89.

About Oragenics

Oragenics, Inc, a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.